nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—L-Phenylalanine—Melphalan—ovarian cancer	0.282	1	CrCrCtD
Selegiline—ABCB1—ovarian cancer	0.221	1	CbGaD
Selegiline—ABCB1—Topotecan—ovarian cancer	0.0343	0.139	CbGbCtD
Selegiline—CYP2C8—Paclitaxel—ovarian cancer	0.0251	0.102	CbGbCtD
Selegiline—ABCB1—Vinorelbine—ovarian cancer	0.0242	0.098	CbGbCtD
Selegiline—CYP2D6—Vinorelbine—ovarian cancer	0.0228	0.0923	CbGbCtD
Selegiline—CYP3A4—Topotecan—ovarian cancer	0.0206	0.0833	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—ovarian cancer	0.0179	0.0723	CbGbCtD
Selegiline—CYP2C9—Paclitaxel—ovarian cancer	0.0175	0.0709	CbGbCtD
Selegiline—ABCB1—Paclitaxel—ovarian cancer	0.017	0.0688	CbGbCtD
Selegiline—CYP3A4—Vinorelbine—ovarian cancer	0.0145	0.0587	CbGbCtD
Selegiline—ABCB1—Docetaxel—ovarian cancer	0.0123	0.0498	CbGbCtD
Selegiline—CYP3A4—Paclitaxel—ovarian cancer	0.0102	0.0412	CbGbCtD
Selegiline—ABCB1—Doxorubicin—ovarian cancer	0.00915	0.0371	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—ovarian cancer	0.00862	0.035	CbGbCtD
Selegiline—CYP3A4—Docetaxel—ovarian cancer	0.00736	0.0298	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—ovarian cancer	0.00548	0.0222	CbGbCtD
Selegiline—Pseudoephedrine—IL2—ovarian cancer	0.000941	1	CrCbGaD
Selegiline—MAOB—myometrium—ovarian cancer	0.000748	0.0426	CbGeAlD
Selegiline—MAOB—embryo—ovarian cancer	0.000719	0.0409	CbGeAlD
Selegiline—MAOA—myometrium—ovarian cancer	0.000638	0.0363	CbGeAlD
Selegiline—MAOA—embryo—ovarian cancer	0.000614	0.0349	CbGeAlD
Selegiline—MAOB—uterine cervix—ovarian cancer	0.000582	0.0331	CbGeAlD
Selegiline—MAOB—decidua—ovarian cancer	0.000554	0.0316	CbGeAlD
Selegiline—CYP2A6—vagina—ovarian cancer	0.000534	0.0304	CbGeAlD
Selegiline—MAOB—endometrium—ovarian cancer	0.000526	0.03	CbGeAlD
Selegiline—MAOA—uterine cervix—ovarian cancer	0.000497	0.0283	CbGeAlD
Selegiline—MAOB—uterus—ovarian cancer	0.000485	0.0276	CbGeAlD
Selegiline—MAOA—decidua—ovarian cancer	0.000473	0.0269	CbGeAlD
Selegiline—MAOA—endometrium—ovarian cancer	0.000449	0.0256	CbGeAlD
Selegiline—MAOB—female reproductive system—ovarian cancer	0.000436	0.0248	CbGeAlD
Selegiline—MAOA—uterus—ovarian cancer	0.000414	0.0236	CbGeAlD
Selegiline—CYP2C8—endometrium—ovarian cancer	0.0004	0.0228	CbGeAlD
Selegiline—MAOB—female gonad—ovarian cancer	0.000397	0.0226	CbGeAlD
Selegiline—MAOB—vagina—ovarian cancer	0.000394	0.0224	CbGeAlD
Selegiline—MAOA—female reproductive system—ovarian cancer	0.000372	0.0212	CbGeAlD
Selegiline—MAOB—testis—ovarian cancer	0.000352	0.02	CbGeAlD
Selegiline—CYP2C19—vagina—ovarian cancer	0.000344	0.0196	CbGeAlD
Selegiline—MAOA—female gonad—ovarian cancer	0.000339	0.0193	CbGeAlD
Selegiline—MAOA—vagina—ovarian cancer	0.000336	0.0192	CbGeAlD
Selegiline—CYP2B6—gonad—ovarian cancer	0.000333	0.019	CbGeAlD
Selegiline—CYP2C8—female reproductive system—ovarian cancer	0.000332	0.0189	CbGeAlD
Selegiline—MAOA—testis—ovarian cancer	0.0003	0.0171	CbGeAlD
Selegiline—CYP2C8—vagina—ovarian cancer	0.0003	0.0171	CbGeAlD
Selegiline—CYP2B6—female reproductive system—ovarian cancer	0.000298	0.0169	CbGeAlD
Selegiline—CYP2C9—female reproductive system—ovarian cancer	0.000295	0.0168	CbGeAlD
Selegiline—CYP2E1—female reproductive system—ovarian cancer	0.000279	0.0159	CbGeAlD
Selegiline—ABCB1—myometrium—ovarian cancer	0.000273	0.0155	CbGeAlD
Selegiline—CYP2B6—vagina—ovarian cancer	0.000269	0.0153	CbGeAlD
Selegiline—CYP2C8—testis—ovarian cancer	0.000268	0.0152	CbGeAlD
Selegiline—ABCB1—embryo—ovarian cancer	0.000262	0.0149	CbGeAlD
Selegiline—MAOB—lymph node—ovarian cancer	0.000255	0.0145	CbGeAlD
Selegiline—CYP2B6—testis—ovarian cancer	0.00024	0.0137	CbGeAlD
Selegiline—CYP2E1—testis—ovarian cancer	0.000225	0.0128	CbGeAlD
Selegiline—CYP3A4—female reproductive system—ovarian cancer	0.000225	0.0128	CbGeAlD
Selegiline—CYP2D6—female reproductive system—ovarian cancer	0.000221	0.0126	CbGeAlD
Selegiline—MAOA—lymph node—ovarian cancer	0.000218	0.0124	CbGeAlD
Selegiline—ABCB1—epithelium—ovarian cancer	0.000214	0.0122	CbGeAlD
Selegiline—ABCB1—uterine cervix—ovarian cancer	0.000212	0.0121	CbGeAlD
Selegiline—ABCB1—decidua—ovarian cancer	0.000202	0.0115	CbGeAlD
Selegiline—CYP2D6—female gonad—ovarian cancer	0.000201	0.0115	CbGeAlD
Selegiline—ABCB1—endometrium—ovarian cancer	0.000192	0.0109	CbGeAlD
Selegiline—CYP2D6—testis—ovarian cancer	0.000178	0.0102	CbGeAlD
Selegiline—ABCB1—gonad—ovarian cancer	0.000178	0.0101	CbGeAlD
Selegiline—ABCB1—uterus—ovarian cancer	0.000177	0.0101	CbGeAlD
Selegiline—ABCB1—female reproductive system—ovarian cancer	0.000159	0.00905	CbGeAlD
Selegiline—ABCB1—bone marrow—ovarian cancer	0.00015	0.00855	CbGeAlD
Selegiline—ABCB1—female gonad—ovarian cancer	0.000145	0.00824	CbGeAlD
Selegiline—ABCB1—vagina—ovarian cancer	0.000144	0.00819	CbGeAlD
Selegiline—ABCB1—testis—ovarian cancer	0.000128	0.00731	CbGeAlD
Selegiline—ABCB1—lymph node—ovarian cancer	9.3e-05	0.0053	CbGeAlD
Selegiline—Arthralgia—Docetaxel—ovarian cancer	8.61e-05	0.000404	CcSEcCtD
Selegiline—Myalgia—Docetaxel—ovarian cancer	8.61e-05	0.000404	CcSEcCtD
Selegiline—Chest pain—Docetaxel—ovarian cancer	8.61e-05	0.000404	CcSEcCtD
Selegiline—Nausea—Vinorelbine—ovarian cancer	8.6e-05	0.000404	CcSEcCtD
Selegiline—Dyspepsia—Paclitaxel—ovarian cancer	8.57e-05	0.000403	CcSEcCtD
Selegiline—Neuropathy peripheral—Epirubicin—ovarian cancer	8.55e-05	0.000402	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	8.55e-05	0.000402	CcSEcCtD
Selegiline—Stomatitis—Epirubicin—ovarian cancer	8.51e-05	0.0004	CcSEcCtD
Selegiline—Urinary tract infection—Epirubicin—ovarian cancer	8.48e-05	0.000399	CcSEcCtD
Selegiline—Conjunctivitis—Epirubicin—ovarian cancer	8.48e-05	0.000399	CcSEcCtD
Selegiline—Dysuria—Doxorubicin—ovarian cancer	8.47e-05	0.000398	CcSEcCtD
Selegiline—Decreased appetite—Paclitaxel—ovarian cancer	8.46e-05	0.000398	CcSEcCtD
Selegiline—Dry mouth—Docetaxel—ovarian cancer	8.42e-05	0.000396	CcSEcCtD
Selegiline—Gastrointestinal disorder—Paclitaxel—ovarian cancer	8.41e-05	0.000395	CcSEcCtD
Selegiline—Fatigue—Paclitaxel—ovarian cancer	8.39e-05	0.000394	CcSEcCtD
Selegiline—Sweating—Epirubicin—ovarian cancer	8.37e-05	0.000393	CcSEcCtD
Selegiline—Pollakiuria—Doxorubicin—ovarian cancer	8.37e-05	0.000393	CcSEcCtD
Selegiline—Constipation—Paclitaxel—ovarian cancer	8.33e-05	0.000391	CcSEcCtD
Selegiline—Pain—Paclitaxel—ovarian cancer	8.33e-05	0.000391	CcSEcCtD
Selegiline—Haematuria—Epirubicin—ovarian cancer	8.32e-05	0.000391	CcSEcCtD
Selegiline—Confusional state—Docetaxel—ovarian cancer	8.32e-05	0.000391	CcSEcCtD
Selegiline—Photosensitivity reaction—Doxorubicin—ovarian cancer	8.27e-05	0.000388	CcSEcCtD
Selegiline—Hepatobiliary disease—Epirubicin—ovarian cancer	8.25e-05	0.000388	CcSEcCtD
Selegiline—Oedema—Docetaxel—ovarian cancer	8.25e-05	0.000388	CcSEcCtD
Selegiline—Weight increased—Doxorubicin—ovarian cancer	8.24e-05	0.000387	CcSEcCtD
Selegiline—Epistaxis—Epirubicin—ovarian cancer	8.23e-05	0.000387	CcSEcCtD
Selegiline—Infection—Docetaxel—ovarian cancer	8.2e-05	0.000385	CcSEcCtD
Selegiline—Weight decreased—Doxorubicin—ovarian cancer	8.19e-05	0.000385	CcSEcCtD
Selegiline—Sinusitis—Epirubicin—ovarian cancer	8.19e-05	0.000385	CcSEcCtD
Selegiline—Hyperglycaemia—Doxorubicin—ovarian cancer	8.17e-05	0.000384	CcSEcCtD
Selegiline—Pneumonia—Doxorubicin—ovarian cancer	8.12e-05	0.000382	CcSEcCtD
Selegiline—Shock—Docetaxel—ovarian cancer	8.12e-05	0.000381	CcSEcCtD
Selegiline—Nervous system disorder—Docetaxel—ovarian cancer	8.09e-05	0.00038	CcSEcCtD
Selegiline—Thrombocytopenia—Docetaxel—ovarian cancer	8.08e-05	0.00038	CcSEcCtD
Selegiline—Drowsiness—Doxorubicin—ovarian cancer	8.08e-05	0.000379	CcSEcCtD
Selegiline—Tachycardia—Docetaxel—ovarian cancer	8.05e-05	0.000378	CcSEcCtD
Selegiline—Feeling abnormal—Paclitaxel—ovarian cancer	8.02e-05	0.000377	CcSEcCtD
Selegiline—Skin disorder—Docetaxel—ovarian cancer	8.02e-05	0.000377	CcSEcCtD
Selegiline—Bradycardia—Epirubicin—ovarian cancer	7.98e-05	0.000375	CcSEcCtD
Selegiline—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.96e-05	0.000374	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.92e-05	0.000372	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—ovarian cancer	7.87e-05	0.00037	CcSEcCtD
Selegiline—Anorexia—Docetaxel—ovarian cancer	7.87e-05	0.00037	CcSEcCtD
Selegiline—Rhinitis—Epirubicin—ovarian cancer	7.85e-05	0.000369	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—ovarian cancer	7.85e-05	0.000369	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—ovarian cancer	7.85e-05	0.000369	CcSEcCtD
Selegiline—Hepatitis—Epirubicin—ovarian cancer	7.83e-05	0.000368	CcSEcCtD
Selegiline—Hypoaesthesia—Epirubicin—ovarian cancer	7.8e-05	0.000366	CcSEcCtD
Selegiline—Pharyngitis—Epirubicin—ovarian cancer	7.78e-05	0.000365	CcSEcCtD
Selegiline—Sweating—Doxorubicin—ovarian cancer	7.74e-05	0.000364	CcSEcCtD
Selegiline—Urinary tract disorder—Epirubicin—ovarian cancer	7.74e-05	0.000364	CcSEcCtD
Selegiline—Urticaria—Paclitaxel—ovarian cancer	7.73e-05	0.000363	CcSEcCtD
Selegiline—Oedema peripheral—Epirubicin—ovarian cancer	7.72e-05	0.000363	CcSEcCtD
Selegiline—Hypotension—Docetaxel—ovarian cancer	7.71e-05	0.000362	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—ovarian cancer	7.7e-05	0.000362	CcSEcCtD
Selegiline—Body temperature increased—Paclitaxel—ovarian cancer	7.7e-05	0.000362	CcSEcCtD
Selegiline—Abdominal pain—Paclitaxel—ovarian cancer	7.7e-05	0.000362	CcSEcCtD
Selegiline—Urethral disorder—Epirubicin—ovarian cancer	7.68e-05	0.000361	CcSEcCtD
Selegiline—Hepatobiliary disease—Doxorubicin—ovarian cancer	7.64e-05	0.000359	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—ovarian cancer	7.62e-05	0.000358	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—ovarian cancer	7.58e-05	0.000356	CcSEcCtD
Selegiline—Visual impairment—Epirubicin—ovarian cancer	7.55e-05	0.000355	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Docetaxel—ovarian cancer	7.52e-05	0.000353	CcSEcCtD
Selegiline—Insomnia—Docetaxel—ovarian cancer	7.46e-05	0.000351	CcSEcCtD
Selegiline—Paraesthesia—Docetaxel—ovarian cancer	7.41e-05	0.000348	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—ovarian cancer	7.38e-05	0.000347	CcSEcCtD
Selegiline—Dyspnoea—Docetaxel—ovarian cancer	7.36e-05	0.000346	CcSEcCtD
Selegiline—Somnolence—Docetaxel—ovarian cancer	7.34e-05	0.000345	CcSEcCtD
Selegiline—Tinnitus—Epirubicin—ovarian cancer	7.3e-05	0.000343	CcSEcCtD
Selegiline—Flushing—Epirubicin—ovarian cancer	7.27e-05	0.000342	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—ovarian cancer	7.27e-05	0.000341	CcSEcCtD
Selegiline—Dyspepsia—Docetaxel—ovarian cancer	7.26e-05	0.000341	CcSEcCtD
Selegiline—Hepatitis—Doxorubicin—ovarian cancer	7.25e-05	0.000341	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—ovarian cancer	7.21e-05	0.000339	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—ovarian cancer	7.19e-05	0.000338	CcSEcCtD
Selegiline—Decreased appetite—Docetaxel—ovarian cancer	7.17e-05	0.000337	CcSEcCtD
Selegiline—Hypersensitivity—Paclitaxel—ovarian cancer	7.17e-05	0.000337	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—ovarian cancer	7.16e-05	0.000336	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—ovarian cancer	7.14e-05	0.000336	CcSEcCtD
Selegiline—Gastrointestinal disorder—Docetaxel—ovarian cancer	7.12e-05	0.000335	CcSEcCtD
Selegiline—Fatigue—Docetaxel—ovarian cancer	7.11e-05	0.000334	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—ovarian cancer	7.11e-05	0.000334	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—ovarian cancer	7.11e-05	0.000334	CcSEcCtD
Selegiline—Pain—Docetaxel—ovarian cancer	7.06e-05	0.000332	CcSEcCtD
Selegiline—Constipation—Docetaxel—ovarian cancer	7.06e-05	0.000332	CcSEcCtD
Selegiline—Chills—Epirubicin—ovarian cancer	7.03e-05	0.00033	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—ovarian cancer	7e-05	0.000329	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—ovarian cancer	6.99e-05	0.000328	CcSEcCtD
Selegiline—Asthenia—Paclitaxel—ovarian cancer	6.99e-05	0.000328	CcSEcCtD
Selegiline—Alopecia—Epirubicin—ovarian cancer	6.92e-05	0.000325	CcSEcCtD
Selegiline—Pruritus—Paclitaxel—ovarian cancer	6.89e-05	0.000324	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—ovarian cancer	6.86e-05	0.000322	CcSEcCtD
Selegiline—Erythema—Epirubicin—ovarian cancer	6.82e-05	0.00032	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—ovarian cancer	6.82e-05	0.00032	CcSEcCtD
Selegiline—Feeling abnormal—Docetaxel—ovarian cancer	6.8e-05	0.00032	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—ovarian cancer	6.76e-05	0.000318	CcSEcCtD
Selegiline—Gastrointestinal pain—Docetaxel—ovarian cancer	6.75e-05	0.000317	CcSEcCtD
Selegiline—Flushing—Doxorubicin—ovarian cancer	6.73e-05	0.000316	CcSEcCtD
Selegiline—Flatulence—Epirubicin—ovarian cancer	6.72e-05	0.000316	CcSEcCtD
Selegiline—Tension—Epirubicin—ovarian cancer	6.69e-05	0.000314	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—ovarian cancer	6.68e-05	0.000314	CcSEcCtD
Selegiline—Diarrhoea—Paclitaxel—ovarian cancer	6.66e-05	0.000313	CcSEcCtD
Selegiline—Nervousness—Epirubicin—ovarian cancer	6.62e-05	0.000311	CcSEcCtD
Selegiline—Back pain—Epirubicin—ovarian cancer	6.6e-05	0.00031	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—ovarian cancer	6.58e-05	0.000309	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—ovarian cancer	6.56e-05	0.000308	CcSEcCtD
Selegiline—Body temperature increased—Docetaxel—ovarian cancer	6.52e-05	0.000307	CcSEcCtD
Selegiline—Abdominal pain—Docetaxel—ovarian cancer	6.52e-05	0.000307	CcSEcCtD
Selegiline—Chills—Doxorubicin—ovarian cancer	6.5e-05	0.000306	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—ovarian cancer	6.48e-05	0.000304	CcSEcCtD
Selegiline—Dizziness—Paclitaxel—ovarian cancer	6.44e-05	0.000302	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—ovarian cancer	6.43e-05	0.000302	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—ovarian cancer	6.41e-05	0.000301	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—ovarian cancer	6.35e-05	0.000298	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—ovarian cancer	6.33e-05	0.000297	CcSEcCtD
Selegiline—Erythema—Doxorubicin—ovarian cancer	6.31e-05	0.000296	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—ovarian cancer	6.31e-05	0.000296	CcSEcCtD
Selegiline—Anaemia—Epirubicin—ovarian cancer	6.3e-05	0.000296	CcSEcCtD
Selegiline—Agitation—Epirubicin—ovarian cancer	6.27e-05	0.000294	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—ovarian cancer	6.22e-05	0.000292	CcSEcCtD
Selegiline—Tension—Doxorubicin—ovarian cancer	6.19e-05	0.000291	CcSEcCtD
Selegiline—Vomiting—Paclitaxel—ovarian cancer	6.19e-05	0.000291	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—ovarian cancer	6.18e-05	0.00029	CcSEcCtD
Selegiline—Malaise—Epirubicin—ovarian cancer	6.15e-05	0.000289	CcSEcCtD
Selegiline—Rash—Paclitaxel—ovarian cancer	6.14e-05	0.000288	CcSEcCtD
Selegiline—Dermatitis—Paclitaxel—ovarian cancer	6.13e-05	0.000288	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—ovarian cancer	6.13e-05	0.000288	CcSEcCtD
Selegiline—Vertigo—Epirubicin—ovarian cancer	6.13e-05	0.000288	CcSEcCtD
Selegiline—Syncope—Epirubicin—ovarian cancer	6.12e-05	0.000287	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—ovarian cancer	6.1e-05	0.000287	CcSEcCtD
Selegiline—Back pain—Doxorubicin—ovarian cancer	6.1e-05	0.000287	CcSEcCtD
Selegiline—Headache—Paclitaxel—ovarian cancer	6.1e-05	0.000287	CcSEcCtD
Selegiline—Hypersensitivity—Docetaxel—ovarian cancer	6.08e-05	0.000286	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—ovarian cancer	6.07e-05	0.000285	CcSEcCtD
Selegiline—Palpitations—Epirubicin—ovarian cancer	6.03e-05	0.000283	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—ovarian cancer	5.99e-05	0.000282	CcSEcCtD
Selegiline—Cough—Epirubicin—ovarian cancer	5.95e-05	0.00028	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—ovarian cancer	5.95e-05	0.000279	CcSEcCtD
Selegiline—Asthenia—Docetaxel—ovarian cancer	5.92e-05	0.000278	CcSEcCtD
Selegiline—Convulsion—Epirubicin—ovarian cancer	5.91e-05	0.000278	CcSEcCtD
Selegiline—Hypertension—Epirubicin—ovarian cancer	5.89e-05	0.000277	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—ovarian cancer	5.86e-05	0.000275	CcSEcCtD
Selegiline—Pruritus—Docetaxel—ovarian cancer	5.84e-05	0.000274	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—ovarian cancer	5.83e-05	0.000274	CcSEcCtD
Selegiline—Myalgia—Epirubicin—ovarian cancer	5.81e-05	0.000273	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—ovarian cancer	5.81e-05	0.000273	CcSEcCtD
Selegiline—Chest pain—Epirubicin—ovarian cancer	5.81e-05	0.000273	CcSEcCtD
Selegiline—Agitation—Doxorubicin—ovarian cancer	5.8e-05	0.000272	CcSEcCtD
Selegiline—Anxiety—Epirubicin—ovarian cancer	5.79e-05	0.000272	CcSEcCtD
Selegiline—Nausea—Paclitaxel—ovarian cancer	5.78e-05	0.000272	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.77e-05	0.000271	CcSEcCtD
Selegiline—Discomfort—Epirubicin—ovarian cancer	5.74e-05	0.00027	CcSEcCtD
Selegiline—Malaise—Doxorubicin—ovarian cancer	5.69e-05	0.000267	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—ovarian cancer	5.68e-05	0.000267	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—ovarian cancer	5.67e-05	0.000266	CcSEcCtD
Selegiline—Syncope—Doxorubicin—ovarian cancer	5.66e-05	0.000266	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—ovarian cancer	5.65e-05	0.000265	CcSEcCtD
Selegiline—Diarrhoea—Docetaxel—ovarian cancer	5.65e-05	0.000265	CcSEcCtD
Selegiline—Confusional state—Epirubicin—ovarian cancer	5.61e-05	0.000264	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—ovarian cancer	5.58e-05	0.000262	CcSEcCtD
Selegiline—Oedema—Epirubicin—ovarian cancer	5.57e-05	0.000262	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—ovarian cancer	5.55e-05	0.000261	CcSEcCtD
Selegiline—Infection—Epirubicin—ovarian cancer	5.53e-05	0.00026	CcSEcCtD
Selegiline—Cough—Doxorubicin—ovarian cancer	5.51e-05	0.000259	CcSEcCtD
Selegiline—Shock—Epirubicin—ovarian cancer	5.48e-05	0.000257	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—ovarian cancer	5.47e-05	0.000257	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—ovarian cancer	5.46e-05	0.000256	CcSEcCtD
Selegiline—Dizziness—Docetaxel—ovarian cancer	5.46e-05	0.000256	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—ovarian cancer	5.45e-05	0.000256	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—ovarian cancer	5.45e-05	0.000256	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—ovarian cancer	5.43e-05	0.000255	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—ovarian cancer	5.41e-05	0.000254	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—ovarian cancer	5.38e-05	0.000253	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—ovarian cancer	5.37e-05	0.000252	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—ovarian cancer	5.37e-05	0.000252	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—ovarian cancer	5.37e-05	0.000252	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—ovarian cancer	5.35e-05	0.000252	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	5.34e-05	0.000251	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—ovarian cancer	5.31e-05	0.000249	CcSEcCtD
Selegiline—Anorexia—Epirubicin—ovarian cancer	5.31e-05	0.000249	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—ovarian cancer	5.25e-05	0.000247	CcSEcCtD
Selegiline—Vomiting—Docetaxel—ovarian cancer	5.25e-05	0.000247	CcSEcCtD
Selegiline—Rash—Docetaxel—ovarian cancer	5.2e-05	0.000244	CcSEcCtD
Selegiline—Hypotension—Epirubicin—ovarian cancer	5.2e-05	0.000244	CcSEcCtD
Selegiline—Dermatitis—Docetaxel—ovarian cancer	5.2e-05	0.000244	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—ovarian cancer	5.19e-05	0.000244	CcSEcCtD
Selegiline—Headache—Docetaxel—ovarian cancer	5.17e-05	0.000243	CcSEcCtD
Selegiline—Oedema—Doxorubicin—ovarian cancer	5.15e-05	0.000242	CcSEcCtD
Selegiline—Infection—Doxorubicin—ovarian cancer	5.12e-05	0.00024	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—ovarian cancer	5.07e-05	0.000238	CcSEcCtD
Selegiline—Shock—Doxorubicin—ovarian cancer	5.07e-05	0.000238	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—ovarian cancer	5.05e-05	0.000237	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—ovarian cancer	5.04e-05	0.000237	CcSEcCtD
Selegiline—Insomnia—Epirubicin—ovarian cancer	5.03e-05	0.000237	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—ovarian cancer	5.03e-05	0.000236	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—ovarian cancer	5e-05	0.000235	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—ovarian cancer	5e-05	0.000235	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—ovarian cancer	4.98e-05	0.000234	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—ovarian cancer	4.96e-05	0.000233	CcSEcCtD
Selegiline—Somnolence—Epirubicin—ovarian cancer	4.95e-05	0.000232	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—ovarian cancer	4.91e-05	0.000231	CcSEcCtD
Selegiline—Nausea—Docetaxel—ovarian cancer	4.9e-05	0.00023	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—ovarian cancer	4.9e-05	0.00023	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—ovarian cancer	4.84e-05	0.000227	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—ovarian cancer	4.81e-05	0.000226	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.81e-05	0.000226	CcSEcCtD
Selegiline—Fatigue—Epirubicin—ovarian cancer	4.8e-05	0.000225	CcSEcCtD
Selegiline—Constipation—Epirubicin—ovarian cancer	4.76e-05	0.000224	CcSEcCtD
Selegiline—Pain—Epirubicin—ovarian cancer	4.76e-05	0.000224	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.69e-05	0.00022	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—ovarian cancer	4.66e-05	0.000219	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—ovarian cancer	4.62e-05	0.000217	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—ovarian cancer	4.59e-05	0.000216	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—ovarian cancer	4.59e-05	0.000216	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—ovarian cancer	4.58e-05	0.000215	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—ovarian cancer	4.55e-05	0.000214	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—ovarian cancer	4.53e-05	0.000213	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—ovarian cancer	4.48e-05	0.00021	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.45e-05	0.000209	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—ovarian cancer	4.44e-05	0.000209	CcSEcCtD
Selegiline—Urticaria—Epirubicin—ovarian cancer	4.42e-05	0.000208	CcSEcCtD
Selegiline—Constipation—Doxorubicin—ovarian cancer	4.4e-05	0.000207	CcSEcCtD
Selegiline—Pain—Doxorubicin—ovarian cancer	4.4e-05	0.000207	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—ovarian cancer	4.4e-05	0.000207	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—ovarian cancer	4.4e-05	0.000207	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—ovarian cancer	4.24e-05	0.000199	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—ovarian cancer	4.21e-05	0.000198	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—ovarian cancer	4.1e-05	0.000193	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—ovarian cancer	4.09e-05	0.000192	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—ovarian cancer	4.07e-05	0.000191	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—ovarian cancer	4.07e-05	0.000191	CcSEcCtD
Selegiline—Asthenia—Epirubicin—ovarian cancer	3.99e-05	0.000188	CcSEcCtD
Selegiline—Pruritus—Epirubicin—ovarian cancer	3.94e-05	0.000185	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—ovarian cancer	3.81e-05	0.000179	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—ovarian cancer	3.79e-05	0.000178	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—ovarian cancer	3.7e-05	0.000174	CcSEcCtD
Selegiline—Dizziness—Epirubicin—ovarian cancer	3.68e-05	0.000173	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—ovarian cancer	3.64e-05	0.000171	CcSEcCtD
Selegiline—Vomiting—Epirubicin—ovarian cancer	3.54e-05	0.000166	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—ovarian cancer	3.52e-05	0.000166	CcSEcCtD
Selegiline—Rash—Epirubicin—ovarian cancer	3.51e-05	0.000165	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—ovarian cancer	3.51e-05	0.000165	CcSEcCtD
Selegiline—Headache—Epirubicin—ovarian cancer	3.49e-05	0.000164	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—ovarian cancer	3.41e-05	0.00016	CcSEcCtD
Selegiline—Nausea—Epirubicin—ovarian cancer	3.31e-05	0.000155	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—ovarian cancer	3.27e-05	0.000154	CcSEcCtD
Selegiline—Rash—Doxorubicin—ovarian cancer	3.25e-05	0.000153	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—ovarian cancer	3.24e-05	0.000152	CcSEcCtD
Selegiline—Headache—Doxorubicin—ovarian cancer	3.23e-05	0.000152	CcSEcCtD
Selegiline—Nausea—Doxorubicin—ovarian cancer	3.06e-05	0.000144	CcSEcCtD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.34e-05	0.000701	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.34e-05	0.000699	CbGpPWpGaD
Selegiline—MAOB—Metabolism—TYMS—ovarian cancer	1.32e-05	0.000691	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—MAPK1—ovarian cancer	1.3e-05	0.00068	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PPP1CC—ovarian cancer	1.29e-05	0.000674	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—BRIP1—ovarian cancer	1.29e-05	0.000674	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—BRIP1—ovarian cancer	1.26e-05	0.00066	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PPP1CC—ovarian cancer	1.26e-05	0.00066	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYTB—ovarian cancer	1.25e-05	0.000653	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.22e-05	0.000638	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.2e-05	0.000625	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.18e-05	0.000614	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.14e-05	0.000598	CbGpPWpGaD
Selegiline—MAOA—Metabolism—FASN—ovarian cancer	1.13e-05	0.000588	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYTB—ovarian cancer	1.12e-05	0.000583	CbGpPWpGaD
Selegiline—MAOA—Metabolism—SLC5A5—ovarian cancer	1.11e-05	0.000579	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.09e-05	0.000571	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.09e-05	0.000571	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.09e-05	0.000571	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.09e-05	0.00057	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.09e-05	0.00057	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYTB—ovarian cancer	1.09e-05	0.000569	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.09e-05	0.000568	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—YAP1—ovarian cancer	1.07e-05	0.00056	CbGpPWpGaD
Selegiline—MAOA—Metabolism—SLC2A1—ovarian cancer	1.07e-05	0.000559	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.07e-05	0.000557	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CAV1—ovarian cancer	1.07e-05	0.000557	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.06e-05	0.000551	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—HRAS—ovarian cancer	1.05e-05	0.000546	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NME2—ovarian cancer	1.04e-05	0.000544	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.04e-05	0.000542	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.03e-05	0.000537	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYTB—ovarian cancer	1.03e-05	0.000536	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP1B1—ovarian cancer	1.03e-05	0.000536	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYTB—ovarian cancer	1.02e-05	0.000531	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1e-05	0.000523	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	9.95e-06	0.000519	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PPP1CC—ovarian cancer	9.76e-06	0.000509	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—BRIP1—ovarian cancer	9.76e-06	0.000509	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CG—ovarian cancer	9.71e-06	0.000507	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PPP1CC—ovarian cancer	9.52e-06	0.000497	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—BRIP1—ovarian cancer	9.52e-06	0.000497	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	9.33e-06	0.000487	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PPP2R1A—ovarian cancer	9.1e-06	0.000475	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	9.05e-06	0.000473	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PPP1CC—ovarian cancer	8.97e-06	0.000469	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—BRIP1—ovarian cancer	8.97e-06	0.000469	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PPP1CC—ovarian cancer	8.9e-06	0.000464	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—BRIP1—ovarian cancer	8.9e-06	0.000464	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—FASN—ovarian cancer	8.75e-06	0.000457	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYTB—ovarian cancer	8.7e-06	0.000454	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—YAP1—ovarian cancer	8.66e-06	0.000452	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—SLC5A5—ovarian cancer	8.61e-06	0.000449	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	8.56e-06	0.000447	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CD—ovarian cancer	8.54e-06	0.000446	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.5e-06	0.000444	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—YAP1—ovarian cancer	8.48e-06	0.000443	CbGpPWpGaD
Selegiline—MAOA—Metabolism—ABCB1—ovarian cancer	8.45e-06	0.000441	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	8.33e-06	0.000435	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—SLC2A1—ovarian cancer	8.31e-06	0.000434	CbGpPWpGaD
Selegiline—MAOA—Metabolism—TYMS—ovarian cancer	8.3e-06	0.000433	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	8.15e-06	0.000425	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	8.15e-06	0.000425	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP1B1—ovarian cancer	7.97e-06	0.000416	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.97e-06	0.000416	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	7.7e-06	0.000402	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—BRIP1—ovarian cancer	7.6e-06	0.000397	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PPP1CC—ovarian cancer	7.6e-06	0.000397	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CB—ovarian cancer	7.44e-06	0.000388	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—YAP1—ovarian cancer	7.33e-06	0.000383	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.26e-06	0.000379	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.11e-06	0.000371	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	7.07e-06	0.000369	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	7.07e-06	0.000369	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—FASN—ovarian cancer	7.06e-06	0.000369	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—SLC5A5—ovarian cancer	6.94e-06	0.000363	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—FASN—ovarian cancer	6.91e-06	0.000361	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.84e-06	0.000357	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—SLC5A5—ovarian cancer	6.8e-06	0.000355	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYTB—ovarian cancer	6.71e-06	0.00035	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—SLC2A1—ovarian cancer	6.71e-06	0.00035	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CAV1—ovarian cancer	6.69e-06	0.000349	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—SLC2A1—ovarian cancer	6.57e-06	0.000343	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ABCB1—ovarian cancer	6.56e-06	0.000343	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—YAP1—ovarian cancer	6.54e-06	0.000342	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.48e-06	0.000338	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.48e-06	0.000338	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—TYMS—ovarian cancer	6.45e-06	0.000336	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP1B1—ovarian cancer	6.43e-06	0.000336	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTEN—ovarian cancer	6.43e-06	0.000336	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—YAP1—ovarian cancer	6.39e-06	0.000333	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.38e-06	0.000333	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP1B1—ovarian cancer	6.3e-06	0.000329	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CG—ovarian cancer	6.09e-06	0.000318	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—YAP1—ovarian cancer	6.02e-06	0.000314	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—FASN—ovarian cancer	5.98e-06	0.000312	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—YAP1—ovarian cancer	5.97e-06	0.000312	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.91e-06	0.000308	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—SLC5A5—ovarian cancer	5.88e-06	0.000307	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.87e-06	0.000306	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.87e-06	0.000306	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.78e-06	0.000302	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	5.7e-06	0.000298	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.69e-06	0.000297	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.68e-06	0.000296	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	5.59e-06	0.000292	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.56e-06	0.00029	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.54e-06	0.000289	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.44e-06	0.000284	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CD—ovarian cancer	5.36e-06	0.00028	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—FASN—ovarian cancer	5.33e-06	0.000279	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ABCB1—ovarian cancer	5.3e-06	0.000276	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5.25e-06	0.000274	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—FASN—ovarian cancer	5.21e-06	0.000272	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—TYMS—ovarian cancer	5.2e-06	0.000271	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CAV1—ovarian cancer	5.19e-06	0.000271	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.19e-06	0.000271	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ABCB1—ovarian cancer	5.19e-06	0.000271	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.12e-06	0.000267	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—YAP1—ovarian cancer	5.1e-06	0.000266	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—TYMS—ovarian cancer	5.09e-06	0.000266	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—SLC2A1—ovarian cancer	5.07e-06	0.000265	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.05e-06	0.000263	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.96e-06	0.000259	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—SLC2A1—ovarian cancer	4.95e-06	0.000258	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—FASN—ovarian cancer	4.91e-06	0.000256	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—FASN—ovarian cancer	4.86e-06	0.000254	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.86e-06	0.000254	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.83e-06	0.000252	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SLC5A5—ovarian cancer	4.83e-06	0.000252	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.8e-06	0.000251	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.78e-06	0.00025	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.74e-06	0.000248	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CG—ovarian cancer	4.73e-06	0.000247	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CB—ovarian cancer	4.67e-06	0.000244	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SLC2A1—ovarian cancer	4.66e-06	0.000243	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.62e-06	0.000241	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—ovarian cancer	4.54e-06	0.000237	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.53e-06	0.000236	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.48e-06	0.000234	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP1B1—ovarian cancer	4.47e-06	0.000233	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.44e-06	0.000232	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.43e-06	0.000231	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—TYMS—ovarian cancer	4.4e-06	0.00023	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.31e-06	0.000225	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.29e-06	0.000224	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.21e-06	0.00022	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CAV1—ovarian cancer	4.19e-06	0.000219	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CD—ovarian cancer	4.16e-06	0.000217	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—FASN—ovarian cancer	4.16e-06	0.000217	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CAV1—ovarian cancer	4.1e-06	0.000214	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.09e-06	0.000213	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTEN—ovarian cancer	4.03e-06	0.000211	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ABCB1—ovarian cancer	4e-06	0.000209	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	3.96e-06	0.000207	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.95e-06	0.000206	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—YAP1—ovarian cancer	3.94e-06	0.000205	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—TYMS—ovarian cancer	3.93e-06	0.000205	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.93e-06	0.000205	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.91e-06	0.000204	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.87e-06	0.000202	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—TYMS—ovarian cancer	3.84e-06	0.0002	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.82e-06	0.000199	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.79e-06	0.000198	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.74e-06	0.000195	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—ovarian cancer	3.71e-06	0.000193	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ABCB1—ovarian cancer	3.68e-06	0.000192	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.65e-06	0.00019	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CB—ovarian cancer	3.62e-06	0.000189	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—TYMS—ovarian cancer	3.61e-06	0.000189	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—TYMS—ovarian cancer	3.58e-06	0.000187	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CAV1—ovarian cancer	3.55e-06	0.000185	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.39e-06	0.000177	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.36e-06	0.000175	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.36e-06	0.000175	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.34e-06	0.000174	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.29e-06	0.000172	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.23e-06	0.000169	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—FASN—ovarian cancer	3.21e-06	0.000167	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CAV1—ovarian cancer	3.17e-06	0.000165	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.16e-06	0.000165	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTEN—ovarian cancer	3.13e-06	0.000164	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.12e-06	0.000163	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CAV1—ovarian cancer	3.09e-06	0.000161	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—TYMS—ovarian cancer	3.06e-06	0.00016	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.05e-06	0.000159	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.03e-06	0.000158	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CB—ovarian cancer	2.92e-06	0.000153	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.92e-06	0.000153	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CAV1—ovarian cancer	2.91e-06	0.000152	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CAV1—ovarian cancer	2.89e-06	0.000151	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.88e-06	0.000151	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.86e-06	0.00015	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—ovarian cancer	2.85e-06	0.000149	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.84e-06	0.000148	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.82e-06	0.000147	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.76e-06	0.000144	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CG—ovarian cancer	2.65e-06	0.000138	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.63e-06	0.000137	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.59e-06	0.000135	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.54e-06	0.000132	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTEN—ovarian cancer	2.53e-06	0.000132	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.48e-06	0.000129	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTEN—ovarian cancer	2.48e-06	0.000129	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.47e-06	0.000129	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CAV1—ovarian cancer	2.47e-06	0.000129	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.41e-06	0.000126	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TYMS—ovarian cancer	2.36e-06	0.000123	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.36e-06	0.000123	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.33e-06	0.000122	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—ovarian cancer	2.33e-06	0.000121	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.31e-06	0.000121	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.25e-06	0.000117	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.21e-06	0.000115	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—ovarian cancer	2.21e-06	0.000115	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.16e-06	0.000113	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTEN—ovarian cancer	2.14e-06	0.000112	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.03e-06	0.000106	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.02e-06	0.000105	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.98e-06	0.000103	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTEN—ovarian cancer	1.91e-06	9.97e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CAV1—ovarian cancer	1.9e-06	9.94e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTEN—ovarian cancer	1.86e-06	9.73e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—ovarian cancer	1.81e-06	9.42e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.78e-06	9.31e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTEN—ovarian cancer	1.76e-06	9.17e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.75e-06	9.12e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTEN—ovarian cancer	1.74e-06	9.09e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.73e-06	9.05e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.72e-06	8.99e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.52e-06	7.96e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.51e-06	7.88e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTEN—ovarian cancer	1.49e-06	7.77e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—ovarian cancer	1.46e-06	7.6e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—ovarian cancer	1.43e-06	7.45e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.35e-06	7.03e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.33e-06	6.94e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.32e-06	6.87e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.24e-06	6.47e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—ovarian cancer	1.23e-06	6.44e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.23e-06	6.41e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTEN—ovarian cancer	1.15e-06	6e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—ovarian cancer	1.1e-06	5.75e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—ovarian cancer	1.07e-06	5.61e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.05e-06	5.48e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—ovarian cancer	1.01e-06	5.28e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—ovarian cancer	1e-06	5.24e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—ovarian cancer	8.58e-07	4.48e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.1e-07	4.23e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—ovarian cancer	6.62e-07	3.46e-05	CbGpPWpGaD
